Cullinan Oncology announces the departure of Dr. Patrick Baeuerle as Chief Scientific Officer and his transition to Co-Founder, Chief Scientific Advisor, with a consulting agreement and compensation details. The company also reports the results of the Annual Meeting of Stockholders, including the election of directors and ratification of the appointment of an independent registered accounting firm.